KRAS G12C inhibitor 37 is a selective inhibitor targeting the KRAS G12C mutation, a key driver in various cancers. This compound displays significant efficacy in disrupting KRAS-mediated signaling pathways, thus impeding tumor growth and proliferation. KRAS G12C inhibitor 37 is intended for research applications focused on elucidating the therapeutic potential in KRAS G12C-driven malignancies.
KRAS G12C inhibitor 37 is a selective inhibitor targeting the KRAS G12C mutation, a key driver in various cancers. This compound displays significant efficacy in disrupting KRAS-mediated signaling pathways, thus impeding tumor growth and proliferation. KRAS G12C inhibitor 37 is intended for research applications focused on elucidating the therapeutic potential in KRAS G12C-driven malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
